XIAP and ovarian carcinoma: A study reported that Akt phosphorylation could inhibit XIAP ubiquitination, reduce its degradation, and partially reverse cisplatin-induced apoptosis of ovarian cancer epithelial cells [40], indicating that XIAP can be an Akt substrate.